Isaac O. Karikari, MD
Lopid dosages: 300 mg
Lopid packs: 30 pills, 60 pills, 90 pills, 120 pills, 180 pills, 270 pills, 360 pills
It is difficult to compare the results of resection with cryotherapy because the reported series generally are not comparable in terms of tumor characteristics medications over the counter cheap lopid 300 mg with amex. The median survival is approximately 30 months, with 5-year actuarial survival of 30% to 40%. Because of patient selection and the combination of therapies used with cryotherapy, comparisons with other modalities are, for the most part, meaningless. Future directions may include hepatic artery infusional chemotherapy after ablative therapies for unresectable tumors. Liver Metastases Liver metastases arising from colorectal, lung, pancreas, and stomach primary tumors constitute the most common malignant tumors of the liver (see Chapters 92-94). Most cancers that metastasize to the liver do so in combination with extrahepatic dissemination. Of the approximately 160,000 new cases each year, liver metastases develop in half of patients within 5 years of diagnosis. Metastatic disease confined to the liver develops in approximately 20% of these patients (16,000 patients). Only a quarter (4000-5000 patients) are amenable to hepatic resection with curative intent. The remaining 12,000 patients with liver-only colorectal metastases are candidates for regional therapies to the liver. The number of patients considered for liver resection is now increasing because of improved resection techniques and dramatic improvements in adjuvant chemotherapy. The ultimate goal of regional treatment of liver metastases is increased survival. Long-term follow-up of patients after cryotherapy for liver metastases is inadequate. Most published studies do not have follow-up exceeding 2 years, and fewer groups have treated enough patients to draw valid conclusions regarding the efficacy of cryotherapy in this setting. Series with adequate follow-up to reporting 3-year and 5-year survival have been published, but with relatively small numbers. In addition, cryotherapy has been used primarily as a salvage procedure or in combination with other treatment modalities, including resection or hepatic artery ligation or infusion, which obscures the results for cryotherapy alone. Most series report median overall survival of about 2 years after cryoablation of liver metastases (Table 98D. In 24 patients treated with cryotherapy, regardless of whether the ablation was complete, Ravikumar and associates (1991b) reported disease-free and overall survival rates of 24% and 63%, respectively. Similarly, Weaver and colleagues (1995) found that 11% of patients were disease free at a mean follow-up of 30 months, and 62% of treated patients were alive at 24 months after cryoablation. Seifert and Morris (1998), in a series of 116 patients with colorectal metastases, showed a median survival of 26 months, and 13% of patients were alive at 5 years. Other publications have reported 4-year and 5-year actuarial survival ranging from 22% to 36% (Kerkar et al, 2004; Rivoire et al, 2002; Seifert & Junginger 2004). Despite the wide variation in outcome with cryotherapy, some patients in each of the series achieved durable survival with this treatment.
Syndromes
This changing treatment paradigm in patients with hepatic colorectal metastases medications zopiclone purchase 300 mg lopid mastercard, with chemotherapy playing an increasingly prominent role, has yet to evolve in other malignant diseases; however, as more effective drugs emerge, it is more than likely that similar changes in practice will be seen in other tumor types. Advances in imaging technology deserve special mention, because patient selection is continually refined. Whereas radiologic evaluation once required invasive investigations in many cases, it can now provide complete, noninvasive assessment of the liver, including the biliary tree, the arterial and venous anatomy, and the intrahepatic and extrahepatic disease extent in the case of malignant disease (see Chapters 15, 18, and 19). Indeed, for certain tumors, classic imaging findings are now considered pathognomonic and have supplanted the need for a biopsy. Specific examples in this regard include liver hemangiomata and focal nodular hyperplasia (see Chapter 19) and the guidelines for the diagnosis of hepatocellular carcinoma (Bruix & Sherman, 2005). Going forward, advances in imaging technology likely to influence the practice of hepatic resectional surgery include computer-aided reconstruction, functional imaging, and intraoperative navigation (Cherqui & Belghiti, 2009; Chopra et al, 2010). Technical progress in other areas, particularly with devices such as vascular staplers and those used to transect the liver parenchyma (see Chapters 103B to D and 108B), is often hailed as a significant advance; however, although their value should not be dismissed, they cannot overcome poorly conceived or poorly executed operations, and their relative contribution, compared with the enhancements in other aspects, is modest at best. Advances in imaging have also played a major role in postoperative management, particularly in diagnosing and treating postoperative complications. During the past several years, the marked reduction in operative mortality after hepatic resection has seemingly occurred with little obvious change in morbidity. This observation suggests an overall improvement in the ability to salvage patients who experience significant complications. The ready availability of high-quality imaging and a heightened sense of awareness of the perioperative problems that may occur have led to earlier detection of complications. These changes, combined with the ability to manage many problems percutaneously or endoscopically, rather than operatively, have clearly had a major impact on perioperative outcome. The descriptions herein reflect the current state of the art, built upon the collective contributions of many pioneering surgeons over the past several decades and continuing to the present. The techniques and approaches discussed include, to some degree, the biases of the authors; however, the overriding theme is always adherence to best principles of hepatic resection surgery, and alternative viewpoints must be considered where appropriate. Maithel Hepatic resection may be necessary for the treatment of a wide variety of conditions involving the liver and biliary tract (Box 103B. The most common indication for partial hepatectomy is removal of metastatic lesions (see Chapters 92-94), which may also include removal of benign and malignant primary tumors of the liver and biliary tract (Chapters 47, 49-51, 90A, 91, and 95). In addition, hepatic resection may be used to treat complex or symptomatic cystic disease of the liver (see Chapter 90B), to allow access for the repair of select benign biliary strictures (Chapter 42), and occasionally to manage hepatic trauma (see Chapter 122).
The concern arises particularly when associated with liver disease medicine for runny nose 300 mg lopid with visa, because the aneurysm may predispose to thrombosis with severe clinical consequences. Therapeutic options range from anticoagulation, either as prophylaxis or for management of thrombosis (Condat & Valla, 2006: Kocher & Himmelmann, 2005), to percutaneous intervention (Condat & Valla, 2006). Surgical correction is rarely required but has been described (Brock et al, 1997; Fulcher & Turner, 1997; Lopez-Machado et al, 1998). Asymptomatic cases without evidence of liver disease or worrisome features such as calcification may simply be managed with surveillance to identify progression or complication (Lopez-Machado et al, 1998). Hepatic atrophy has been reported as a result of reduced blood flow, oxygenation, or supply of hypertrophic factors. Elevated blood ammonia and galactose levels can be seen from direct delivery of splanchnic blood into the systemic circulation without metabolic clearance by the liver. Recently, Blanc and colleagues (2014) proposed a new classification based on anatomy, as well as a surgical approach based on the location of the shunt, the status of the intrahepatic portal venous system, and operative approach. Angiographic occlusion of shunts using plugs, stents, or coils can be performed, although use of these approaches if often limited in cases of short, wide shunts because of the risk of plug or coil migration (Guerin et al, 2012). In cases where the shunt cannot be successfully divided in one stage, a band or ligature is placed around the shunt to decrease flow and promote development of intrahepatic portal flow (Blanc et al, 2014). Radiation therapy has been used for extensive lesions affecting the entire gland, with good short-term and intermediate-term results (Sato et al, 2003; Shimizu et al, 2013). Surgical resection, including pancreaticoduodenectomy, distal pancreatectomy, and even total pancreatectomy, has been reported (Makhoul et al, 2008; Sharma et al, 2011; Song et al, 2012). Embolization has been recommended before surgical resection to reduce bleeding (Iwashita et al, 2002; Rezende et al, 2003). However, given the increased facility of endovascular approaches, surgical therapy should be reserved for larger or refractory lesions. Concomitant visceral aneurysms are seen in 3% of cases, whereas nonvisceral aneurysms, particularly of the renal arteries, are seen in 12%. Three quarters of aneurysms are located in the distal artery, and 20% are located in the middle third of the vessel. Calcification of the aneurysm wall can be seen in many aneurysms and is thought to be the result of arterial wall degradation rather than associated with atherosclerosis; it is seen in the wall of ruptured aneurysms and therefore should not be seen as a sign of aneurysm stability (Mattar & Lumsden, 1995). Calcification of the aneurysm appears to be negatively correlated by size (Lakin et al, 2011). Congenital lesions account for 80% to 90% of cases, and the original case report described such a case in a patient with Osler-WeberRendu syndrome (Halpern et al, 1968). Acquired lesions are typically the result of inflammation, malignancy, or trauma and even occur after transplantation (Butte et al, 2007; Nishiyama et al, 2000). The most common location is the head (40%-50%), followed by the body and tail (>30%) and entire gland (>14%) (De Robertis Lombardi et al, 2013; Kanno et al, 2006; Takemoto et al, 2007). Less frequently, patients may present with abdominal pain or jaundice, or rarely pancreatitis, although many are asymptomatic (Charalabopoulos et al, 2011; Makhoul et al, 2008; Ohtani et al, 1992).
In this situation medications you cant take while breastfeeding order lopid 300 mg fast delivery, patients should be warned of this effect, especially if they are being treated on an outpatient basis. Patients have taken as much as 50 times the therapeutic doses of benzodiazepines without causing mortality. This particular property of these drugs is another example of how they differ from the potent respiratory depressant sedatives and hypnotics. Unlike the barbiturates, the benzodiazepines have only a mild effect on respiration when given orally, even with toxic doses. However, when they are administered parenterally or are taken in conjunction with other depressants such as alcohol, all benzodiazepines have the potential of causing significant respiratory depression and death. The benzodiazepines are well known to produce physical dependence, and withdrawal reactions ensue upon abrupt discontinuation. The dependence associated with the benzodiazepines is not the same as that observed with alcohol, opioids, or the barbiturates. Although physical dependence is more likely to occur with high drug doses and long-term treatment, it has also been reported after usual therapeutic regimens. Again, because of the hepatic biotransformation of these compounds, special care must be taken when prescribing benzodiazepines for individuals with hepatic dysfunction and for the aged and debilitated population. These patients generally have a diminished liver-detoxifying capacity and often show cumulative toxicity in response to the usual adult dosage, especially of agents metabolized to active metabolites with long half-lives (diazepam, chlordiazepoxide). The aged are also more prone to acute depression of attention, alertness, motor dexterity, and sensory acuity as well as memory disturbance and confusion. For this reason, doses in the aged should be started at 25% of the usual adult dose and administered less frequently. As with other psychoactive medications, precautions should be given with respect to administration of the drug and the amount of the prescription for severely depressed patients or for those in whom there is reason to suspect concealed suicidal ideation or plans. Adverse reactions of buspirone include dizziness, drowsiness, dry mouth, headaches, nervousness, fatigue, insomnia, weakness, lightheadedness, and muscle spasms. When administered chronically, buspirone causes less tolerance and potential for abuse than the benzodiazepines and does not produce a rebound effect after discontinuation. The problems associated with the use of the antidepressants and anxiolytics are summarized in the Clinical Problems Box. With the longer-acting benzodiazepines, the onset of withdrawal is much slower because of their longer half-lives and slower disappearance from the plasma. Therefore doses of the benzodiazepines with short half-lives should be decreased more gradually. In addition, alprazolam, estazolam, and triazolam, which have a chemical structure (triazolo ring) that differs from the other benzodiazepines and are referred to as triazolobenzodiazepines, cause more serious withdrawal reactions than the other compounds.
Transcatheter Yttrium-90 Radioembolization Radioembolization is a transcatheter therapy performed by interventional radiologists medications errors buy lopid 300 mg visa. The tumor is approached by using its arterial supply, and the vial is injected into the vessel feeding the tumor. The distribution of the tumor is the factor that allows the treatment to be selective, allowing delivery to one lobe, or superselective, allowing delivery to one segment. The critical organs include the bone marrow, lung, and normal liver, and the dose limitations to them are 1. It has the ability to liquefy in an acidic environment and form a gel in basic environments, and the gel has embolic effects. Microspheres of 166Ho poly-L-lactic acid are being studied in animal models and have been shown to be safe, but they have yet to be studied in humans (Vente et al, 2010). Its use in the management of cholangiocarcinoma (see Chapter 50) has also been studied. Patients should be selected for this treatment modality based on a consensus of the team. As discussed later, the role of radioembolization is not limited by the stage of the disease, but no survival benefit has been seen in patients with distant metastases. Phosphorus-32 Glass Microspheres Overview 32 P is a radioisotope that emits high-energy -particles during decay. It is administered as an integral constituent of nonbiodegradable glass microspheres. Resection is possible only if liver function is preserved (see Chapters 3 and 103D). Thermal ablation (radiofrequency ablation) has a limited role because of the risk of tract seeding and the size and location of tumor (see Chapters 98B and 98C). The administration is via a transarterial approach, after angiography has been performed to study the vascular anatomy of the liver. Conclusion the half-life of this radionuclide gives it the advantage of a lower required dose and a potential to have a decreased radiation exposure to handlers compared with the other radionuclides available. It has been tolerated well in animal and human trials, although its role in the management of liver tumors is yet to be established. Systemic therapy with sorafenib has been shown to have a statistically significant improvement in survival in patients with advanced disease (Llovet et al, 2008) (see Chapter 88). However, 90Y may be used in these cases because of its minimal embolic effect (Kulik et al, 2007). A survival benefit has not been shown in patients with distant metastases (Salem et al, 2010). The presence of multiple metastases and comorbidities limits the role of surgical resection in these patients (Welsh et al, 2006). The role of radioembolization alone and as a conjunct to systemic chemotherapy has been well established. Patient Selection for Radioembolization in the Management of Metastatic Liver Disease: General Considerations General considerations must be taken before the use of radioembolization for metastatic liver disease.
N-Acetyl-L-Carnitine (Acetyl-L-Carnitine). Lopid.
Source: http://www.rxlist.com/script/main/art.asp?articlekey=96809
The systemic venous system develops from the anterior and posterior cardinal veins symptoms zinc poisoning discount lopid 300 mg online, whereas the afferent (portal) system arises from the vitelline and umbilical veins. The system gradually develops by processes of vascular coalescence and cellular differentiation that culminate in separate arterial and venous conduits. Congenital intrahepatic shunts are rare anomalies characterized by abnormal communication between the hepatic arterial system, portal veins, hepatic veins, or systemic veins as a result of disordered embryologic development about the fifth gestational week. The right and left vittelline veins pass around the duodenum and enter the septum transversum (primitive liver), where they are broken up into sinusoids by the developing liver parenchyma before draining into the sinus venosus. The left vitelline vein then involutes, and blood from the right vitelline vein is distributed to both sides of the liver. The right and left umbilical veins begin with two branches; one drains directly into the sinus venosus, and the other enters into the hepatic sinusoids. The umbilical vein branches into the sinus venosus and eventually Chapter 124 Aneurysm and arteriovenous fistula of the liver and pancreatic vasculature 1911 involutes, directing all blood toward the liver (Gallego et al, 2004; Guerin et al, 2012). Variations in embryologic development yield several dominant patterns that can have implications for the surgeon (see Chapter 2). These anatomic variants are typically asymptomatic, but a few rare anomalies can have clinical implications. Portal vein duplication is a rare anomaly resulting from atypical fusion of the superior and inferior mesenteric veins. Portal hypertension resulting in formation of varices may also occur, but the mechanism is unclear. It is also of further significance in the adult population because its presence, and the associated derangement of the mesentericoportal confluence, can complicate the surgical approach to the pancreas. The spectrum of malformations that bears his name, the clinical consequences, and treatment options are discussed in detail later. Outcomes depend on the specific type of malformation and the presence or absence of congenital heart disease and liver disease (Hu et al, 2008). Aneurysms of the portal venous system represent 3% of all venous aneurysms and are the most common visceral aneurysm (Fulcher & Turner, 1997; Gallego et al, 2002; Ohnami et al, 1997). Although the majority of lesions are thought to be acquired phenomena associated with intrinsic liver disease (Blasbalg et al, 2000), congenital aneurysms have been identified in utero (Fulcher & Turner, 1997). Many of these lesions are identified incidentally on cross-sectional imaging and are usually asymptomatic. Approximately 10% of lesions will require treatment based on increasing size, with a media growth rate of 0.
In addition treatment questionnaire lopid 300 mg on line, most phagocytic cells have receptors for the Fc portion of IgG, allowing them to actively engulf antibody-coated cells. Isotype switching is the process of shifting from the initial heavy-chain IgM to one of four types to improve function and specialization of the secreted antibody. IgG is the most significant soluble mediator of opsonization and is the dominant antibody produced in response to alloantigen. The resultant B-cell clones have altered antigen affinity, thus the term affinity maturation (Griffiths et al, 1984). Clones that have higher affinity for the target antigen have a selective survival advantage and form the basis for a more vigorous response on reexposure to the antigen. The type of costimulatory signal received by the lymphocyte determines whether the cell will become activated, remain quiescent, die, or become resistant to subsequent immune stimulation. The biology of T-cell costimulation is substantially more developed than that of B-cell costimulation. Therefore, sites of trauma that recruit platelets create an environment of activating costimulatory molecules, thereby bridging the innate and acquired immune systems (Czapiga et al, 2004). Soluble mediators of communication known as cytokines, or interleukins, are polypeptides that are released from many cells; they can either activate or suppress adjacent cells (Arai et al, 1990), and the pattern of cytokine expression is thought to influence the resultant type of T-cell response (Mosmann, 1991; Mosmann et al, 1986). In addition to cytokines, other soluble mediators of inflammation are capable of promoting increased blood flow and improved exposure of an area of injury to innate and acquired immune elements. This nonphysiologic recognition provides the opportunity for a detrimental immune response but does not mandate it in the absence of additional contextual requirements for immunity-like costimulation. Thus alloimmunity is more likely than autoimmunity but is not mandated in the absence of costimulation, innate immunity, or other factors that elicit a physiologic immune response. Many of these cells are crossreactive with antigen encountered during prior viral exposures, or even with autoantigens, as in the case of autoimmune disease. This is known as heterologous immunity and results in a situation whereby recipients have allospecific memory without having been exposed to the alloantigen (Adams et al, 2003a, 2003b). In addition, adhesion and costimulation molecules are upregulated perioperatively (Hoffmann et al, 2002; Takada et al, 1997). Initial T-cell binding to donor cells is nonspecific, mediated by adhesion molecules upregulated during donor cell activation (Fuggle & Koo, 1998). The resultant cytokine milieu recruits more T cells to the site of injury and potentiates clonal expansion. Although acute rejection is the result of T-cell activation, antibody responses accompany many episodes. Cellular and soluble components of immunity mediate multiple distinct clinical rejection syndromes through cytokine-mediated toxicity, cellular cytotoxicity, and direct effects of antibody and complement.
If diagnosis is prompt treatment zone guiseley cheap lopid 300 mg buy, emergency exploration with attempted thrombectomy and revascularization may salvage the graft, although this is usually not possible. Some reports suggest that endovascular procedures- intraarterial thrombolysis, percutaneous transluminal angioplasty, and endoluminal stenting-can be successful in hepatic arterial revascularization (Singhal et al, 2010). However, a majority of patients eventually require retransplantation (Bekker et al, 2009; Duffy et al, 2009). Clinical presentation may be asymptomatic or may result in perihepatic abscess, biliary leak, biliary strictures, or cholangitis (Gunsar et al, 2003). Treatment may be attempted with endoscopic or percutaneous biliary decompression, stenting, or even systemic anticoagulation. Systemic anticoagulation may be sufficient in patients with preserved graft function (Duffy et al, 2009). Symptoms of portal hypertension but preserved graft function often can be managed medically with standard therapies for ascites in combination with variceal banding or sclerotherapy; however, the graft salvage rate with these alternative strategies is typically much less than 50% (Duffy et al, 2009) (see Chapter 120). The most common area of stenosis is the extrahepatic portal venous anastomotic site. Many stenoses can be managed endovascularly with percutaneous transhepatic balloon angioplasty and stenting (Woo et al, 2007) (see Chapter 120). Biliary strictures occur twice as frequently as anastomotic biliary leaks and can be classified as anastomotic or nonanastomotic (ischemic cholangiopathy) (Balsells et al, 1995; Qian et al, 2004). Most anastomotic strictures are managed endoscopically with balloon dilation and stenting. Ischemic cholangiopathy more often results from bile duct ischemia or an immune response, appears later and affects multiple sites, tends to be more difficult to manage, and is rarely amenable to endoscopic treatment. Nonanastomotic strictures are associated with a higher rate of graft failure requiring retransplantation (Axelrod et al, 2014; Chan et al, 2008; de Vera et al, 2009; Pine et al, 2009). A multidisciplinary approach to diagnosis and management of biliary complications is necessary and can result in higher patient and graft survival rates (Verran et al, 1997). In an asymptomatic patient with stable liver function, biliary complications can often be managed nonoperatively. Major leaks or total disruption usually requires operative conversion to a choledochojejunostomy or hepaticojejunostomy, an option that can result in long-term biliary patency (Langer et al, 2009). Initial presentation typically includes a mild increase in transaminase levels with or without associated graft dysfunction or biliary complications. Restenosis can occur in as many as one-third of patients within 1 year after stenting (Ueno et al, 2006) (see Chapter 120).
Hepatic resection by extended left hepatectomy was successfully carried out medicine of the people lopid 300 mg purchase with amex, and the patient was alive and well for more than 7 years. Assessment of Resectability Resectability is defined not only by what can be removed but, more importantly, by what can be left behind. In many cases, minimal difficulty is associated with assessing tumor resectability on preoperative imaging. This is particularly true for lesions situated in the periphery, at some distance from the major vascular structures, and with no radiologic evidence of additional tumors. At operation, however, some patients may be found to have unexpected lymph node involvement or additional liver lesions visualized during laparoscopy or open exploration. This situation often relates to the oncologic appropriateness of resection, which should remain distinct from technical resectability. Given the advances and improved clarity of preoperative images, an unexpected finding at operation occurs in a minority of patients. Second, very large tumors, which push structures aside and have been slowly growing during a long time, are difficult to define precisely, because pressure changes may mimic invasion on radiologic images. Thus considerable caution must be exercised before declaring such cases unresectable. When the chest is evaluated, subcentimeter pulmonary nodules are frequently encountered that should not necessarily preclude hepatic resection, particularly for colorectal cancer liver metastases (Maithel et al, 2010). A, Computed tomographic scan shows a large tumor apparent in the right liver and extending well into the left (top arrow). D, Celiac axis angiogram shows the arterial supply to the tumor arising from the left hepatic artery. E, An accessory right hepatic artery is revealed to arise from the superior mesenteric trunk (arrow). F, Late-phase portogram obtained from selective splenic artery catheterization shows tumor involvement of the right branch of the portal vein extending to the portal venous bifurcation (arrows). The tumor proved to be a primary hepatocellular carcinoma, and treatment was by extended right hepatectomy. Note: Angiographic techniques are now rarely used in diagnosis, but the images are retained for illustrative purposes. The morphologic configuration of tumors on imaging studies has been shown to have a clear relationship to subsequent resectability. Tumors that expand and compress surrounding tissues (pushing tumors) and tumors that are pedunculated and attached to the liver by a base of narrow width (hanging tumors) are almost always resectable, and they should be distinguished from tumors that are irregular at the margins and clearly invasive (Baer et al, 1989). In the early years of hepatic resection, the editor emeritus (Leslie H Blumgart) adopted and promoted a deliberate policy of full investigation at laparotomy to assess resectability in all patients with solitary large liver tumors, provided no positive evidence of extrahepatic spread was apparent, patients were otherwise fit for major surgery, and the residual liver would be adequate. Of 22 patients with primary liver cancer evaluated in an early study, 13 patients were explored, and all underwent E. Extended right hepatectomy was done, and tumor clearance was obtained; hepatic vascular isolation was not used. Two of these 13 patients had tumor embolization before surgery to reduce vascularity and tumor size.
Ford, 61 years: Gingival hyperplasia and hirsutism are encountered frequently during cyclosporine and corticosteroid treatment, whereas glucose intolerance is reported more often with tacrolimus than cyclosporine therapy.
Karmok, 26 years: General measures include increasing FiO2, avoidance of hypercapnia and acidosis, and pulmonary vasodilators.
Harek, 53 years: Mantadakis E, et al: Primary hepatic Burkitt lymphoma, Pediatr Hematol Oncol 25(4):331338, 2008.
Hamil, 65 years: Takada T, et al: Contrast-enhanced intraoperative ultrasonography of small hepatocellular carcinoma, Surgery 107:528532, 1990.
Kaffu, 64 years: Saturation of drug-metabolizing enzymes has a pronounced influence on drug-plateau concentrations.
Malir, 58 years: A number of prognostic models have been developed, including both static and time-dependent ones (Neuberger, 1989).
Lukjan, 38 years: Most of these techniques have been abandoned or are used only by a few specialized groups for the following reasons: 1.
Akascha, 51 years: No randomized studies are currently available that demonstrate the positive impact of early extubation, but recent reviews suggest possible outcome and cost benefits (Ozier & Klinck, 2008; Wu et al, 2012).
References